Takarazuka, Japan

Seiji Sawai


Average Co-Inventor Count = 3.4

ph-index = 5

Forward Citations = 182(Granted Patents)


Location History:

  • Neyagawa, JP (1988)
  • Hyogo, JP (2004)
  • Takarazuka, JP (1997 - 2006)

Company Filing History:


Years Active: 1988-2006

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Insights into the Innovations of Inventor Seiji Sawai

Introduction: Seiji Sawai, an innovative inventor based in Takarazuka, Japan, has made significant contributions to the field of pharmaceuticals. With a total of five patents to his name, he has played a crucial role in advancing medical technology and ensuring the stability of pharmaceutical compositions.

Latest Patents: Among Seiji Sawai's latest patents is a stabilized pharmaceutical composition in lyophilized form. This invention includes a cyclic polypeptide compound characterized by a general formula wherein R can be a hydrogen atom or an acyl group. Additionally, R and R can either be hydrogen atoms or hydroxyl groups, or they can exist as a salt. These innovations aim to enhance the stability of pharmaceutical products, ensuring their efficacy and safety for patients.

Career Highlights: Throughout his career, Seiji Sawai has worked with prominent companies in the pharmaceutical sector, including Fujisawa Pharmaceutical Company, Ltd. and Astellas Pharma GmbH. His expertise in pharmaceutical composition has led to advancements that benefit healthcare and improve patient outcomes.

Collaborations: In his journey as an inventor, Seiji Sawai has collaborated with notable professionals, including Akihiro Kasai and Kazumi Ohtomo. These partnerships have facilitated the sharing of knowledge and expertise, playing a significant role in the development of more effective pharmaceutical solutions.

Conclusion: Seiji Sawai's contributions to the field of pharmaceuticals through his inventions and patents not only highlight his innovative spirit but also demonstrate the importance of collaboration in scientific advancements. His work continues to pave the way for future innovations in medication stability and efficacy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…